Normosang (Human Hemin)

Human Hemin, the active ingredient in Normosang, is a heme (porphyrin) derivative presented as a solution for injection for intravenous use. It treats acute intermittent porphyria and other acute hepatic porphyrias in patients experiencing an acute attack.

GNH USA supplies Normosang as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres and pharmacies worldwide.

Normosang is used to manage acute attacks of hepatic porphyria by providing exogenous heme. - Acute intermittent porphyria: reduces neurotoxic precursor accumulation and alleviates symptoms. - Variegate porphyria: helps control acute neurovisceral crises. - Hereditary coproporphyria: mitigates severe abdominal pain and neurological manifestations.

Adverse reactions to Normosang may vary in frequency and severity.

Common Side Effects: - Headache: mild to moderate pain often reported during infusion. - Nausea: transient gastrointestinal discomfort. - Vomiting: occasional episodes post‑administration. - Fever: low‑grade temperature rise. - Injection site pain: local discomfort at the IV site. - Diarrhea: mild loose stools.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Methemoglobinemia: elevated methemoglobin levels causing cyanosis. - Hemolysis: destruction of red blood cells. - Acute renal failure: sudden loss of kidney function. - Thrombophlebitis: inflammation and clot formation at the infusion site.

Before using Normosang, clinicians should consider several precautionary measures to ensure safe administration. - Assess liver function: evaluate hepatic enzymes prior to infusion. - Monitor porphyrin precursors: check urinary ALA and PBG levels during therapy. - Check for hypersensitivity: inquire about previous reactions to hemin products. - Use with caution in renal impairment: adjust monitoring as kidney function may be affected. - Avoid concurrent use with photosensitizing agents: increase risk of phototoxicity. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Normosang may interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid): - Phenobarbital: induces hepatic enzymes, reducing hemin effectiveness. - Phenytoin: similar enzyme induction may diminish therapeutic response. - Oral contraceptives: estrogen‑containing products can increase porphyrin precursor synthesis.

Moderate Interactions (Monitor Closely): - Anticonvulsants (e.g., carbamazepine): may require dose adjustment of hemin. - Iron supplements: excess iron can affect heme metabolism. - Vitamin D analogues: monitor calcium levels as hemin may alter bone metabolism.